Baidu
map

心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 心衰专家共识：优化射血分数降低的心力衰竭的预后改善药物的应用

2021-12-04 国外心血管相关专家小组（统称） Rev Port Cardiol (Engl Ed)

心力衰竭射血分数降低的心衰

射血分数降低的心衰（HFrEF）与高住院率和死亡率相关，近年来，出现了新的HFrEF预后调整药物，本文依据最新发表的临床证据，针对优化HFrEF的预后改善药物的应用提出共识指导。

中文标题：

2021 心衰专家共识：优化射血分数降低的心力衰竭的预后改善药物的应用

英文标题：

Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper

发布机构：

国外心血管相关专家小组（统称）

发布日期：

2021-12-04

简要介绍：

射血分数降低的心衰（HFrEF）与高住院率和死亡率相关，近年来，出现了新的HFrEF预后调整药物，本文依据最新发表的临床证据，针对优化HFrEF的预后改善药物的应用提出共识指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 心衰专家共识：优化射血分数降低心力衰竭改善预后的药物.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4ea641c002298a96, title=2021 心衰专家共识：优化射血分数降低的心力衰竭的预后改善药物的应用, enTitle=Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper, guiderFrom=Rev Port Cardiol (Engl Ed), authorId=0, author=, summary=射血分数降低的心衰（HFrEF）与高住院率和死亡率相关，近年来，出现了新的HFrEF预后调整药物，本文依据最新发表的临床证据，针对优化HFrEF的预后改善药物的应用提出共识指导。, cover=https://img.medsci.cn/20211222/1640165101576_1608702.jpg, journalId=0, articlesId=null, associationId=738, associationName=国外心血管相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Sat Dec 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">射血分数降低的心衰（HFrEF）与高住院率和死亡率相关，近年来，出现了新的HFrEF预后调整药物，本文依据最新发表的临床证据，针对优化HFrEF的预后改善药物的应用提出共识指导。</span></p>, tagList=[TagDto(tagId=335, tagName=心力衰竭), TagDto(tagId=45362, tagName=射血分数降低的心衰)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=335, guiderKeyword=心力衰竭, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2022, appHits=238, showAppHits=0, pcHits=455, showPcHits=1784, likes=2, shares=27, comments=10, approvalStatus=1, publishedTime=Wed Dec 22 17:23:02 CST 2021, publishedTimeString=2021-12-04, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Wed Dec 22 17:29:58 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 22:56:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 心衰专家共识：优化射血分数降低心力衰竭改善预后的药物.pdf)])
2021 心衰专家共识：优化射血分数降低心力衰竭改善预后的药物.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2111194, encodeId=7cf32111194ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Mon Jan 23 08:10:34 CST 2023, time=2023-01-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1084572, encodeId=ace810845e2c3, content=坚持再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 07:25:17 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084250, encodeId=5b9c10842509e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/IIJ5718N61skWVYXHEaXn9D9NRnZWLnAOC87ghicFgwTmuD9K4M4qyicKcbAGeWTZ5xfmJK9k8xmPiaPsd3Cm8S9A/132, createdBy=9eda5269259, createdName=Lulu2303, createdTime=Sat Dec 25 21:38:16 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084183, encodeId=3344108418389, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c26424220, createdName=yzf123, createdTime=Sat Dec 25 17:31:33 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084125, encodeId=301c1084125ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b94763799, createdName=135430b43cm, createdTime=Sat Dec 25 08:49:36 CST 2021, time=2021-12-25, status=1, ipAttribution=)]
    2023-01-23 zmqlk 来自山东省

    学习了

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2111194, encodeId=7cf32111194ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Mon Jan 23 08:10:34 CST 2023, time=2023-01-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1084572, encodeId=ace810845e2c3, content=坚持再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 07:25:17 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084250, encodeId=5b9c10842509e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/IIJ5718N61skWVYXHEaXn9D9NRnZWLnAOC87ghicFgwTmuD9K4M4qyicKcbAGeWTZ5xfmJK9k8xmPiaPsd3Cm8S9A/132, createdBy=9eda5269259, createdName=Lulu2303, createdTime=Sat Dec 25 21:38:16 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084183, encodeId=3344108418389, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c26424220, createdName=yzf123, createdTime=Sat Dec 25 17:31:33 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084125, encodeId=301c1084125ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b94763799, createdName=135430b43cm, createdTime=Sat Dec 25 08:49:36 CST 2021, time=2021-12-25, status=1, ipAttribution=)]
    2021-12-27 ms1000001656413688

    坚持再学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2111194, encodeId=7cf32111194ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Mon Jan 23 08:10:34 CST 2023, time=2023-01-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1084572, encodeId=ace810845e2c3, content=坚持再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 07:25:17 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084250, encodeId=5b9c10842509e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/IIJ5718N61skWVYXHEaXn9D9NRnZWLnAOC87ghicFgwTmuD9K4M4qyicKcbAGeWTZ5xfmJK9k8xmPiaPsd3Cm8S9A/132, createdBy=9eda5269259, createdName=Lulu2303, createdTime=Sat Dec 25 21:38:16 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084183, encodeId=3344108418389, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c26424220, createdName=yzf123, createdTime=Sat Dec 25 17:31:33 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084125, encodeId=301c1084125ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b94763799, createdName=135430b43cm, createdTime=Sat Dec 25 08:49:36 CST 2021, time=2021-12-25, status=1, ipAttribution=)]
    2021-12-25 Lulu2303

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2111194, encodeId=7cf32111194ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Mon Jan 23 08:10:34 CST 2023, time=2023-01-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1084572, encodeId=ace810845e2c3, content=坚持再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 07:25:17 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084250, encodeId=5b9c10842509e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/IIJ5718N61skWVYXHEaXn9D9NRnZWLnAOC87ghicFgwTmuD9K4M4qyicKcbAGeWTZ5xfmJK9k8xmPiaPsd3Cm8S9A/132, createdBy=9eda5269259, createdName=Lulu2303, createdTime=Sat Dec 25 21:38:16 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084183, encodeId=3344108418389, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c26424220, createdName=yzf123, createdTime=Sat Dec 25 17:31:33 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084125, encodeId=301c1084125ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b94763799, createdName=135430b43cm, createdTime=Sat Dec 25 08:49:36 CST 2021, time=2021-12-25, status=1, ipAttribution=)]
    2021-12-25 yzf123

    #心血管#非常好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2111194, encodeId=7cf32111194ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Mon Jan 23 08:10:34 CST 2023, time=2023-01-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1084572, encodeId=ace810845e2c3, content=坚持再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10105725125, createdName=ms1000001656413688, createdTime=Mon Dec 27 07:25:17 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084250, encodeId=5b9c10842509e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/IIJ5718N61skWVYXHEaXn9D9NRnZWLnAOC87ghicFgwTmuD9K4M4qyicKcbAGeWTZ5xfmJK9k8xmPiaPsd3Cm8S9A/132, createdBy=9eda5269259, createdName=Lulu2303, createdTime=Sat Dec 25 21:38:16 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084183, encodeId=3344108418389, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c26424220, createdName=yzf123, createdTime=Sat Dec 25 17:31:33 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084125, encodeId=301c1084125ac, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66b94763799, createdName=135430b43cm, createdTime=Sat Dec 25 08:49:36 CST 2021, time=2021-12-25, status=1, ipAttribution=)]
    2021-12-25 135430b43cm

    学习了

    0

相关指南

2021 ESC共识文件：整合心力衰竭影像学和循环生物标志物

欧洲心脏病学会(ESC,European Society of Cardiology) · 2021-10-23

2021CCS / CHFS《心力衰竭指南更新: 定义新的射血分数降低心力衰竭治疗的药理学标准》解读

四川省医学科学院 · 2021-11-01

2021 临床实践指南：应用体外循环(ECLS/ECMO) 治疗心脏和循环衰竭

国外急诊/重症相关专家小组（统称） · 2021-11-22

2021更新 NICE指南：急性心力衰竭的诊断和管理

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-11-17

沙库巴曲缬沙坦钠共晶物药学特性专家共识

中国药学会医院药学专业委员会 · 2021-08-12

将姑息疗法整合到心力衰竭护理中：欧洲心脏病学会心力衰竭协会立场文件

欧洲心脏病学会(ESC,European Society of Cardiology) · 2021-11-02

拓展阅读

2010 中华医学会 急性心力衰竭诊断和治疗指南

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

心脏再同步治疗慢性心力衰竭的建议（2009年修订版）

中华医学会心电生理和起搏分会 · 2010-02-25

加拿大心衰诊疗指南（2010更新）：少数民族人口，心脏衰竭和怀孕，疾病管理，和质量改进/保证方案心力衰竭

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2010-04-01

2010HFSA 心力衰竭治疗指南

美国心衰学会(HFSA,HEART FAILURE SOCIETY OF AMERICA) · 2010-07-01

2011AHA/ACC 急性心力衰竭综合征：急诊科表现、治疗、处置的现状及预期目的--来自美国心脏病协会科学声明

美国心脏协会(AHA,American Heart Association) · 2011-04-14

2012AHA 科学声明：心力衰竭诊疗进展科学决策

美国心脏协会(AHA,American Heart Association) · 2012-03-05

Baidu
map
Baidu
map
Baidu
map